Rosane de Oliveira Lopes

Rosane de Oliveira Lopes

Auto-generated profile, based on publicly available information

Rosane de Oliveira Lopes


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2021 in International Journal of Cardiovascular Sciences
Verified
Journal Article
Closed access
PDF file
SBStephani Correia Brazão
Stephani Correia Brazão
LALis Jappour Autran
Lis Jappour Autran
RLRosane de Oliveira Lopes
Rosane de Oliveira Lopes
CSCHRISTIANNE BRETAS VIEIRA SCARAMELLO
CHRISTIANNE BRETAS VIEIRA SCARAMELLO
FBFernanda Carla Ferreira de Brito
Fernanda Carla Ferreira de Brito
NMNadia Alice Vieira Motta
Nadia Alice Vieira Motta
Chloroquine (CQ) and Hydroxychloroquine (HCQ) are antimalarial drugs, with anti-inflammatory properties that justify their use in the treatment of systemic lupus erythematosus and rheumatic diseases. A pandemic caused by the new coronavirus led the entire world’s scientific community to look for drugs already available on the market, capable of exercising beneficial actions in the fight against the disease. Preliminary studies in patients, as well as in vitro studies, suggested possible therapeutic effects associated with the use of HCQ and [...] Abstract Chloroquine (CQ) and Hydroxychloroquine (HCQ) are antimalarial drugs, with anti-inflammatory properties that justify their use in the treatment of systemic lupus erythematosus and rheumatic diseases. A pandemic caused by the new coronavirus led the entire world’s scientific community to look for drugs already available on the market, capable of exercising beneficial actions in the fight against the disease. Preliminary studies in patients, as well as in vitro studies, suggested possible therapeutic effects associated with the use of HCQ and